TROPHAMINE 10% Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Trophamine 10%, and when can generic versions of Trophamine 10% launch?
Trophamine 10% is a drug marketed by B Braun and is included in one NDA.
The generic ingredient in TROPHAMINE 10% is amino acids. There are three hundred and fifty drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the amino acids profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Trophamine 10%
A generic version of TROPHAMINE 10% was approved as amino acids by B BRAUN on April 13th, 2012.
Summary for TROPHAMINE 10%
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Clinical Trials: | 2 |
Formulation / Manufacturing: | see details |
DailyMed Link: | TROPHAMINE 10% at DailyMed |
Recent Clinical Trials for TROPHAMINE 10%
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
National Center for Research Resources (NCRR) | N/A |
Baylor College of Medicine | N/A |
National Center for Research Resources (NCRR) | Phase 3 |
Pharmacology for TROPHAMINE 10%
Drug Class | Amino Acid |
Anatomical Therapeutic Chemical (ATC) Classes for TROPHAMINE 10%
US Patents and Regulatory Information for TROPHAMINE 10%
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
B Braun | TROPHAMINE 10% | amino acids | INJECTABLE;INJECTION | 019018-003 | Sep 7, 1988 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |